ACRV
USDAcrivon Therapeutics Inc. Common Stock
$2.150-0.110 (-4.867%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.260
High
$2.300
Low
$2.110
Volume
1.02M
Company Fundamentals
Market Cap
67.6M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.56M
Exchange
NGM
Currency
USD
52-Week Range
Low $1.05Current $2.150High $8.74
Related News
GlobeNewswire
Acrivon Therapeutics Highlights its Powerful Generative Phosphoproteomics AP3 Platform with Compelling Preclinical Data for ACR-2316 with Three Presentations at the Upcoming AACR-NCI-EORTC International Conference
AP3 Generative AI KaiSR model globally assesses drug effects on the entire intracellular protein signaling network for optimal drug design and precision medicine development Favorable ACR-2316 preclinical data,
View more
Related Stocks
FLC
Flaherty & Crumrine Total Return Fund Inc
NASDAQ
Trusts Except E...
TRNR
Interactive Strength Inc.
NASDAQ
Consumer Electr...
CLX
Clorox Company (The)
NASDAQ
Specialty Chemi...
LRCX
Lam Research Corporation
NASDAQ
Industrial Mach...
KTH
Structures Products Cp 8% CorTS Issued by Peco Energy Cap Tr II Preferred Stock
NASDAQ
Finance: Consum...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.